Literature DB >> 23742809

Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors.

Christel Vérollet1, Anne Gallois, Romain Dacquin, Claire Lastrucci, Subramanya N M Pandruvada, Nathalie Ortega, Renaud Poincloux, Annie Behar, Céline Cougoule, Clifford Lowell, Talal Al Saati, Pierre Jurdic, Isabelle Maridonneau-Parini.   

Abstract

In osteoclasts, Src controls podosome organization and bone degradation, which leads to an osteopetrotic phenotype in src(-/-) mice. Since this phenotype was even more severe in src(-/-)hck(-/-) mice, we examined the individual contribution of Hck in bone homeostasis. Compared to wt mice, hck(-/-) mice exhibited an osteopetrotic phenotype characterized by an increased density of trabecular bone and decreased bone degradation, although osteoclastogenesis was not impaired. Podosome organization and matrix degradation were found to be defective in hck(-/-) osteoclast precursors (preosteoclast) but were normal in mature hck(-/-) osteoclasts, probably through compensation by Src, which was specifically overexpressed in mature osteoclasts. As a consequence of podosome defects, the 3-dimensional migration of hck(-/-) preosteoclasts was strongly affected in vitro. In vivo, this translated by altered bone homing of preosteoclasts in hck(-/-) mice: in metatarsals of 1-wk-old mice, when bone formation strongly depends on the recruitment of these cells, reduced numbers of osteoclasts and abnormal developing trabecular bone were observed. This phenotype was still detectable in adults. In summmary, Hck is one of the very few effectors of preosteoclast recruitment described to date and thereby plays a critical role in bone remodeling.

Entities:  

Keywords:  Src tyrosine kinases; cell migration; osteopetrosis; podosomes

Mesh:

Substances:

Year:  2013        PMID: 23742809      PMCID: PMC4046168          DOI: 10.1096/fj.13-232736

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

1.  Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes.

Authors:  Céline Cougoule; Sébastien Carréno; Jerôme Castandet; Arnaud Labrousse; Catherine Astarie-Dequeker; Renaud Poincloux; Véronique Le Cabec; Isabelle Maridonneau-Parini
Journal:  Traffic       Date:  2005-08       Impact factor: 6.215

2.  MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.

Authors:  T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

3.  Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation.

Authors:  Nathalie Ortega; Danielle J Behonick; Céline Colnot; Douglas N W Cooper; Zena Werb
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

4.  Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.

Authors:  P L Schwartzberg; L Xing; O Hoffmann; C A Lowell; L Garrett; B F Boyce; H E Varmus
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

5.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Authors:  H P Gerber; T H Vu; A M Ryan; J Kowalski; Z Werb; N Ferrara
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

6.  Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process.

Authors:  Christelle Villeneuve; Martine Gilleron; Isabelle Maridonneau-Parini; Mamadou Daffé; Catherine Astarie-Dequeker; Gilles Etienne
Journal:  J Lipid Res       Date:  2004-12-01       Impact factor: 5.922

7.  Functional overlap in the src gene family: inactivation of hck and fgr impairs natural immunity.

Authors:  C A Lowell; P Soriano; H E Varmus
Journal:  Genes Dev       Date:  1994-02-15       Impact factor: 11.361

8.  Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells.

Authors:  N Quintrell; R Lebo; H Varmus; J M Bishop; M J Pettenati; M M Le Beau; M O Diaz; J D Rowley
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

9.  Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis.

Authors:  C A Lowell; M Niwa; P Soriano; H E Varmus
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

10.  Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.

Authors:  L Blavier; J M Delaissé
Journal:  J Cell Sci       Date:  1995-12       Impact factor: 5.285

View more
  11 in total

1.  Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.

Authors:  Jonathon Mitchell; Su Jin Kim; Alexandra Seelmann; Brendan Veit; Brooke Shepard; Eunok Im; Sang Hoon Rhee
Journal:  Biochem Pharmacol       Date:  2017-11-23       Impact factor: 5.858

Review 2.  Tools of the trade: podosomes as multipurpose organelles of monocytic cells.

Authors:  Stefan Linder; Christiane Wiesner
Journal:  Cell Mol Life Sci       Date:  2014-10-10       Impact factor: 9.261

Review 3.  Podosome organization drives osteoclast-mediated bone resorption.

Authors:  Dan Georgess; Irma Machuca-Gayet; Anne Blangy; Pierre Jurdic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

4.  Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.

Authors:  Brigitte Raynaud-Messina; Lucie Bracq; Maeva Dupont; Shanti Souriant; Shariq M Usmani; Amsha Proag; Karine Pingris; Vanessa Soldan; Christophe Thibault; Florence Capilla; Talal Al Saati; Isabelle Gennero; Pierre Jurdic; Paul Jolicoeur; Jean-Luc Davignon; Thorsten R Mempel; Serge Benichou; Isabelle Maridonneau-Parini; Christel Vérollet
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

5.  Tyrosine phosphorylation of Wiskott-Aldrich syndrome protein (WASP) by Hck regulates macrophage function.

Authors:  Haein Park; Athanassios Dovas; Samer Hanna; Claire Lastrucci; Celine Cougoule; Romain Guiet; Isabelle Maridonneau-Parini; Dianne Cox
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

6.  RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.

Authors:  Kelsi Andrade; Jaime Fornetti; Ling Zhao; Scott C Miller; R Lor Randall; Neysi Anderson; Susan E Waltz; Mark McHale; Alana L Welm
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

Review 7.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

8.  The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.

Authors:  Ashley Sutherland; Amanda Forsyth; Yingying Cong; Laurel Grant; Tzu-Hua Juan; Jae K Lee; Alexander Klimowicz; Stephanie K Petrillo; Jinghui Hu; Angela Chan; Florence Boutillon; Vincent Goffin; Cay Egan; Patricia A Tang; Li Cai; Don Morris; Anthony Magliocco; Carrie S Shemanko
Journal:  J Natl Cancer Inst       Date:  2015-11-19       Impact factor: 13.506

9.  HIV-1-Infected Human Macrophages, by Secreting RANK-L, Contribute to Enhanced Osteoclast Recruitment.

Authors:  Rémi Mascarau; Florent Bertrand; Arnaud Labrousse; Isabelle Gennero; Renaud Poincloux; Isabelle Maridonneau-Parini; Brigitte Raynaud-Messina; Christel Vérollet
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

10.  Podosomes, But Not the Maturation Status, Determine the Protease-Dependent 3D Migration in Human Dendritic Cells.

Authors:  Céline Cougoule; Claire Lastrucci; Romain Guiet; Rémi Mascarau; Etienne Meunier; Geanncarlo Lugo-Villarino; Olivier Neyrolles; Renaud Poincloux; Isabelle Maridonneau-Parini
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.